Permitted FDA-licensed cell and gene therapy ads in the US
- Date
- May 9, 2022
- Effective
- Jul 1, 2022
- Regions
- United States / Global
- Primary source
- Google Advertising Policies Help
The speculative and experimental medical treatment policy was updated to allow entities holding FDA licenses or approvals to promote cell or gene therapies in the US, and to allow purely educational or informational cell and gene therapy ads globally.
Sources
- open_in_newUpdate to Healthcare and medicines policy (July 2022)Google Advertising Policies Help · May 9, 2022
Related changes
Undo